drugset
drugset / Trial / NCT03936374

A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants

NCT03936374 ↗

Phase 1 Completed 16 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the effect of multiple dose administrations of Omeprazole on the pharmacokinetics of BMS-986205.

Timeline

Start
2019-05-08
Primary completion
2019-07-20
Completion
2019-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject LINRODOSTAT Small molecule — —
Subject Omeprazole Other / unclassified — —

Indications

No indication recorded.